Volume 24, Number 12—December 2018
Research
Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
Table 1
Demographic and clinical characteristics of solid organ transplant recipients, Queen Mary Hospital, Hong Kong, January 1, 2014–December 31, 2017*
Characteristic | Result† |
---|---|
No. transplant recipients |
518 |
Organ transplanted | |
Kidney | 430 (83.0) |
Liver | 61 (11.7) |
Heart | 16 (3.1) |
Lung | 10 (1.9) |
Combined kidney and liver |
1 (0.2) |
Median age, y |
56 |
Sex | |
F | 203 (39.2) |
M |
315 (60.8) |
Prevalence of persistent biochemical hepatitis |
52 (10.2) |
Cause of biochemical hepatitis | |
Viral hepatitis‡ | |
Reactivation of chronic HBV infection | 5 (9.6) |
Chronic HCV infection | 7 (13.5) |
Chronic HEV infection | 5 (9.6) |
CMV reactivation | 8 (15.4) |
Nonviral causes† | |
Drug toxicity | 7 (13.5) |
Nonalcoholic fatty liver disease | 3 (5.8) |
Liver graft rejection | 7 (13.5) |
Biliary anastomotic stricture | 5 (9.6) |
Liver malignancies | 2 (3.8) |
Septic cholestasis | 2 (3.8) |
Recurrent pyogenic cholangitis | 1 (1.9) |
*CMV, cytomegalovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus.
†All results are no. (%) unless otherwise indicated.
‡All percentages based on no. patients with biochemical hepatitis.